UCL awarded £15m EU H2020 TEAMING grant : The Discoveries Centre for Regenerative and Precision Medicine
We are delighted to announce that UCL researchers have been awarded a prestigious EU Horizon 2020 TEAMING grant, in collaboration with a consortium of Portuguese Universities led by Prof Rui L. Reis at 3B´s Research Group of the University of Minho.
Publication date: 15 December 2016
Professor Gill Bates (UCL Institute of Neurology) has been appointed as the new Vice Dean
(Research) for the Faculty of Brain Sciences, as of 1st October 2016,
and we warmly welcome her to the Faculty senior leadership team.
Professor Bates joined UCL in May 2016 as Professor of Molecular Neuroscience and Co-Director of the Huntington's Disease Centre in the Sobell Department of Motor Neuroscience (UCL Institute of Neurology). The research of the Bates lab is focussed on understanding the molecular basis of Huntington’s disease and developing therapeutic interventions.
Professor Bates will play a key role in shaping the Faculty’s research strategy and will work with Faculty leadership and the Office of the Vice Provost (Research) to ensure that Faculty and UCL objectives are aligned. Throughout her career, she has demonstrated a genuine collegiate spirit and she is an inspiring role model to junior researchers. On her appointment, she said: “I am very excited to have been given this opportunity to play an active role in contributing to the Faculty and wider UCL research community.”
Professor Bates takes over this role from Professor Nick Wood, and will continue to build on the superb work that he has done over the past five years. Prof Wood skilfully aligned the Faculty research strategy with the UCLH/UCL BRC neurosciences themes, and contributed enormously to the successful renewal of the BRC funding. He has been a key member of the School Research Board, involved in the triage, peer review and mock interviews for large grant proposals, improving our success rate as a School, of these major grant applications. We are very grateful for all he has achieved.
Publication date: 11 October 2016
A new drug to treat the muscle wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council (MRC) Centre for Neuromuscular Diseases at University College London (UCL) Institute of Neurology and the University of Kansas Medical Center.
Publication date: 30 March 2016
We are delighted to announce that Professor Roger Lemon (Sobell Chair of Neurophysiology, UCL Institute of Neurology) has been awarded the Fyssen International Prize 2015 for his work in Neurocognitive Mechanisms in Sensory and Motor systems.
Publication date: 7 January 2016
the largest trial ever performed, and recruiting the most severely affected
patients with Tourette syndrome, researchers led by Dr Tom Foltynie, UCL Institute of Neurology, have shown that Deep Brain stimulation of an area of the brain
called the globus pallidus (GPi) can lead to significant reduction in tic
severity when stimulation is switched ON compared with when switched OFF.
Publication date: 29 April 2015
Research UK today
announced a £30m Drug Discovery Alliance, launching three flagship Drug
Discovery Institutes at UCL, the University of Cambridge and the
Oxford. The Drug Discovery Institutes will see 90 new research
employed in state-of-the-art facilities to fast-track the development of
treatments for Alzheimer’s disease and other dementias.
Publication date: 16 February 2015
The BRC have awarded over £700,000 to three exciting clinical research projects in neuroscience.
Publication date: 21 January 2015
that tetanus neurotoxin enters nerve cells has been discovered by UCL
scientists, who showed that this process can be blocked, offering a potential
therapeutic intervention for tetanus.
Publication date: 28 November 2014
A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King’s College London, co-led by Professor Linda Greensmith of the MRC Centre for Neuromuscular Diseases at UCL’s Institute of Neurology.
Publication date: 4 April 2014
A drug used to treat patients with diabetes could benefit people with Parkinson’s Disease, according to research led by UCL Institute of Neurology.
Publication date: 22 May 2013
Third International Workshop on Functional Neurosurgery: Movement Disorders, Pain, Psychiatric Illness, Ethics
Thursday 11th October and Friday 12th October 2012 ( two days)
Approved by 12 CPD credits by Royal College of Physicians of London
Workshop organised by Professor Marwan Hariz, Unit of Functional Neurosurgery
To view the final programme (pdf) please click here
Publication date: 12 April 2012
A patient who is part of the first first UK trial to evaluate the impact of 'deep brain stimulation' on Tourette's - a collaboration between the UCL Institute of Neurology (Unit of Functional Neurosurgery) and the National Hospital of Neurology and Neurosurgery - has experienced a dramatic recovery.
Publication date: 2 January 2012
The Institute is delighted to congratulate Professor Roger Lemon on his being honoured by the Betty and David Koetser Foundation for Brain Research.
Publication date: 2 June 2011
13 April 2011
Publication date: 13 April 2011
Publication date: 24 December 2010
The saliva of a venomous lizard native to southwestern America and Mexico could provide a cure for patients with Parkinson’s disease.
Publication date: 27 August 2010
Dr Damon Hoad, from the Sobell Department of Motor Neuroscience and Movement Disorders, took the top honour with his poster on 'Shaping the brain – Transcranial Magnetic Stimulation to study and modulate neuroplasticity'. in a poster presentation competition at the Shape of Science Symposium in Manchester.
Publication date: 9 August 2010
Research carried out by Professor John Rothwell, in the Sobell Department of Motor Neuroscience & Movement Disorders and reported in the Daily Mail reveals the benefits of repetitive transcranial magnetic stimulation (rTMS) in easing the symptoms of tinnitus.
Publication date: 3 February 2009